Pharmaceutical composition containing histone deacetylase inhibitor
An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl) amninomethyl]benzamide (MS-275) and another anticancer active substance.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
08.05.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl) amninomethyl]benzamide (MS-275) and another anticancer active substance. |
---|---|
Bibliography: | Application Number: AU20040241873 |